Chief Complaint Transplant Diagnosis : Acute myelogenous leukemia ( AML ) ( complex cytogentics refractory to chemotherapy ) . 
Date of Transplant : 5/6/2010 . 
Day Post - Transplant : 31 . 
Interval History Diarrhea resolved at this time . 
Nutrition and fluid intake good . 
Pt has new mild patches of rash on bilat inner arms and right flank . 
No pruritis . 
Pt feels increasingly well with improving strength . . 
Pain Management Pain Scale : 0 ( 0 none ; 10 worst ) . 
Patient Controlled Analgesics : Not applicable . 
Transplant Status 
PROTOCOL / TREATMENT PLAN : 739 / 1932 . 
TRANSPLANT TYPE allogeneic unrelated , matched peripheral blood stem cell transplant . 
CMV SEROLOGY Donor negative , Recipient negative . 
PREPARATIVE REGIMEN : Myeloablative TBI , cyclophosphamide . 
GVHD Prophylaxis Methotrexate , Tacrolimus . 
Allergies NKA Medications Scheduled Medications acyclovir 800 mg PO BID beclomethasone 2 mg PO QID ( beclomethasone in corn oil ( conc 1 mg/mL ) ) budesonide 3 mg PO TID ( budesonide 3 mg oral capsule , extended release ) diphenhydrAMINE 25 - 5 0 mg PO Q4 Hours emollients , topical apply to sun exposed areas when outdoors Topical ( sunscreen SPF - 30 - 50 lotion ) fluconazole 400 mg PO QDay heparin flush 3 ml for flush IV magnesium sulfate 64 mEq IV QDay multivitamin no iron 2 tab Chew QDay pantoprazole 40 mg PO QDay sodium chloride 10 ml for flush IV ( Normal Saline Flush ) sulfamethoxazole - trimethoprim 1 tab PO BID on QMTu ( Bactrim DS ) 
tacrolimus 1.5 mg 
PO Q12 Hours ursodiol 600 mg PO BID PRN Medications lidocaine / diphenhydramine / Al - Mg hydroxide magic mouthwash 5 ml Swish & Spit Q4 Hours PRN ( as needed for pain ) 
lorazepam 
0.5 - 2mg PO Q4 Hours PRN ( for nausea / vomiting ) miscellaneous item 1 application Topical PRN ( - ) ( Boston Butt Cream ) 
nepafenac ophthalmic 1 drop ( s ) 
Left EYE TID PRN ( - ) ( Nevanac ) 
ondansetron 8 mg PO Q8 Hours PRN ( for nausea / vomiting ) oxycodone 5 - 1 0 mg PO Q4 Hours PRN ( for pain ) prochlorperazine 10 mg PO Q4 Hours PRN ( for nausea / vomiting ) Review of Systems CONSTITUTIONAL Symptoms Denies fever . 
Denies chills . 
Denies weakness . 
Denies sweats . 
ENMT Denies rhinorrhea . 
Denies oral lesions . 
Denies sinus congestion . 
Denies sore throat . 
CARDIOVASCULAR Symptoms Denies chest pain . 
Denies lightheadedness . 
Denies swelling . 
RESPIRATORY Symptoms Denies cough . 
Denies shortness of breath . 
GASTROINTESTINAL Symptoms denies abdominal pain , denies nausea , denies vomiting , denies diarrhea , denies constipation . 
MUSCULOSKELETAL Symptoms denies muscle pain . 
SKIN Symptoms rash , denies itching . 
NEUROLOGIC Symptoms denies headaches , denies dizziness . 
HEME / LYMPH Symptoms denies bleeding , denies bruising . 
Physical Examination Vital Signs Vital Signs Data . 
06/07/2010 09:16 Temperature - C 36.7 degC Heart Rate 80 bpm Respiratory Rate 16 
br / min 
SBP - Noninvasive 110 mmHg DBP - Noninvasive 76 mmHg BP Method Manual BP Extremity LEFT , Arm , Upper CONSTITUTIONAL : well - appearing , no apparent distress . 
MENTAL STATUS : alert and oriented x3 , Level of Consciousness : alert , normal mood / affect . 
EYES : pupils equal , round , reactive to light , extraocular movements intact , EOMI , normal sclera . 
EARS , NOSE , MOUTH , and THROAT : normal mouth and dentition , normal oropharynx . 
RESPIRATORY / 
CHEST : normal respiratory effort , lung sounds clear to auscultation bilaterally . . 
CARDIOVASCULAR : regular rate and rhythm , no murmur , rub or gallop , no cyanosis or edema . 
GASTROINTESTINAL : normal bowel sounds , abdomen non - tender , abdomen non - distended , no hepatomegaly , no splenomegaly . 
MUSCULOSKELETAL : normal gait / stance . 
SKIN : Lesions / Rash : BSA 6 % , rash , erythema ( mild maculopapular rash at base of throat and patches bilat inner arms and right flank . 
Also fine scattered erythematous papular rash on forearms . ) 
, hickman line intact . 
no erythema , tenderness , inflammation . . 
NEUROLOGIC : 
cranial nerves II - XII intact . 
Laboratory Studies Laboratory Studies ( Most recent results in 24 hour range . ) 
RESULTS FROM TODAY RESULTS FROM YESTERDAY 06/07/10 
08:42 - - - | - ICa - - - | - ICa - - - 141 106 22 | - Ca 9.8 - - - - - - - - - | - Ca - - - - - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 154 | - Mg 1.6 - - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < - - - | - Mg - - - 4.4 25 0.7 | - Phos 4.0 - - - - - - - - - | - Phos - - - RESULTS FROM TODAY RESULTS FROM YESTERDAY 06/07/10 08:42 - - - 12.3 | - PT - - - - - - | - PT - - - 15.72 ] - - - - - - - - - - - - - - - - - - - - - - [ 136 | - INR - - - - - - ] - - - - - - - - - - - - - - - - - - - - - - [ - - - | - INR - - - 37 | - PTT - - - - - - | - PTT - - - ( Most recent results for 24 hour range . ) 
Individual Labs 06/07/2010 08:42 LD ( Total ) 191 06/07/2010 08:42 AST ( GOT ) 15 06/07/2010 08:42 ALT ( GPT ) 16 06/07/2010 08:42 Bilirubin ( Total ) 0.4 06/07/2010 08:42 Bilirubin ( Direct ) 
0.1 06/07/2010 08:42 Protein ( Total ) 6.6 06/07/2010 08:42 Albumin 3.5 06/07/2010 
08:42 MCV 92 06/07/2010 08:42 Neutrophils 11.00 Antibiotics 
No Results Found . 
( Most Recent Results for Prior 7 Days . ) 
Immunosuppressant 06/07/2010 05:00 
Tacrolimus Level by LCMSMS 
Pending ( Most Recent Results for Prior 14 Days . ) 
CMV Results 05/31/2010 09:50 CMV Quant ( PCR ) Result None detected . 
Viral / CMV Monitoring 
Herpes Group - Serology / Molecular DX . 
05/31/2010 09:50 CMV Quant ( PCR ) Interp . 
M13383 CMV Quant ( PCR ) Specimen Plasma ( Modified ) CMV Quant ( PCR ) Result None detected . 
copies / mL CMV Quant ( PCR ) DNA Copies / mL ( Log 10 ) 
Not Calculated Radiological Studies Chest X - Ray : ( 5/23/10 
) Findings / Impression : Lungs clear . 
No pneumothorax is present . 
Right internal jugular catheter are stable . . 
Procedures 
/ Diagnostic Studies PATHOLOGY : BMA 6/3/10 : Pathology : Normocellular bone marrow , day 28 post - transplant , with morphological remission but 1 - 2 % of white cells having phenotypic characteristics of minimal residual disease . 
Flow Cytometry : A very small population of abnormal myeloid blasts is identified with an immunophenotype similar to that seen previously ( see HP1 0 - 05930 ) . 
These blasts comprise approximately 0.006 % of total white cells , and express CD33 ( decreased ) , CD34 ( increased ) , CD117 ( absent ) and HLA - DR ( decreased to absent ) with normal expression of CD13 , CD38 , CD45 and CD71 without CD5 , CD7 , CD15 , CD19 , CD56 , or CD64 . 
This finding is compatible with minimal persistent disease involvement by the patientï¿½s acute myeloid leukemia . . 
Assessment / Plan PRIMARY DISEASE : 45 year old man with refractory AML with complex cytogenetics , now day 31 s/p MURD PBSCT with TBI / Cy conditioning . 
HEMATOLOGIC : platelet threshold : 10 thousand , Hematocrit threshold : 26 % , Engrafted . 
Transfusion independent . 
Leukocytosis : BMA 6/3/10 as above showing possible persistent AMoL . 
CBC differential today shows slightly elevated monocytes , metamyelocytes , and myelocytes . 
Peripheral blood flow cytometry pending for today . 
A discussion will be held with the leukemia service regarding further plans for monitoring or treatment . . 
INFECTIOUS DISEASE : 
Infection Prophylaxis : Antifungal agent ( s ) : 
Fluconazole , Bactrim for PCP prophy , Antiviral agent ( s ) : 
Acyclovir . 
Plan : Afebrile . 
Corona virus positive from 5 / 21 BAL . 
Chest xray clear . 
Nasal congestion resolved . . 
DRUG MONITORING : Tacrolimus : level pending , Tacrolimus goal 5 - 15 . 
GRAFT - VERSUS - HOST 
DISEASE : History of GVHD : GI tract . 
Active SKIN GVHD Assessment : 
Differential Diagnosis : 
GVHD , Drug reaction , contact dermatitis . 
Plan : FK - 506 and post transplant methotrexate prophylaxis . 
New onset diarrhea on 5 / 19 , EGD / Flex Sig 5 / 20 . 
Started empiric beclothemasone and budesonide on 5 / 20 per GI recommendations . 
Most likely conditioning toxicity , c.diff , and antibiotic effect with diarrhea now resolved . 
Final pathology suggestive of residual chemotherapy toxicity versus early GVHD . 
Will stop beclomethasone and continue budesonide with likely stop at next visit . 
Skin rashes with mild suspicion for GVHD . 
Will follow for changes and obtain biopsy if worsening . . 
REGIMEN RELATED TOXICITY : 
Fatigue , weakness : Improved today . 
Continue to follow . . 
GASTROINTESTINAL : Diarrhea , resolved . . 
FLUIDS , ELECTROLYTES & NUTRITION : Hypomagnesemia , requiring daily IV repletion . 
Appetite and food intake signficantly improved . 
Fluid intake adquate , no IV fluids necessary . 
Mag level 1.6 today . 
Continue IV repletion 40 meq BID and slowly start Mag oxide PO . . 
Comments Plan : Follow PB flow today . 
Signature Judson Hall , PA - C FHCRC / SCCA Pager 314 - 0063 
